CheckMyRecalls

Hikma Injectables USA Inc recalls ketamine inj 50 mg per 1 mL and 1 more

Published
8 Jan 2025
Units affected
2 products
Agency
FDA
Country
United States

The hazard

Lack of Assurance of Sterility: The tamper-evident seal on several of the syringes are not attached upon receipt of shipment.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

ketamine inj 50 mg per 1 mL, Rx Only, 1 mL fill in a 3mL pre-filled syringe, For IV or IM Use, Hikma Injectables USA Inc., 36 Stults Road, Dayton, NJ 08810, This is a Compounded Drug. Hospital/Office Use Only. NDC 63037-137-25

phenylephrine in 0.9% Sodium Chloride Inj, 1mg per 10 mL (100 mcg/mL), Rx only, Hikma Injectables USA Inc., 36 Stults Road, Dayton, NJ 08810, NDC 63037-173-25

Brand / company
Hikma Injectables USA Inc
Codes / lots
Lot number: 242560008D, Use by Date 01/15/2025; 242970002D, Use by Date 02/25/2025 | Lot number: 243120003D, Use by Date: 03/11/2025
Distribution
Nationwide in the USA
Recall status
Terminated

Source: U.S. Food and Drug Administration, published 8 Jan 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.